vs
Side-by-side financial comparison of Core Natural Resources, Inc. (CNR) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Core Natural Resources, Inc. is the larger business by last-quarter revenue ($1.0B vs $622.0M, roughly 1.7× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs -7.6%, a 42.0% gap on every dollar of revenue. On growth, Core Natural Resources, Inc. posted the faster year-over-year revenue change (81.8% vs 4.8%). Over the past eight quarters, Core Natural Resources, Inc.'s revenue compounded faster (38.1% CAGR vs 4.6%).
Arch Resources, previously known as Arch Coal, was an American coal mining and processing company. The company mined, processed, and marketed bituminous and sub-bituminous coal with low sulfur content in the United States. Arch Resources was the second-largest supplier of coal in the United States, behind Peabody Energy. As of 2011 the company supplied 15% of the domestic market. Demand came mainly from generators of electricity.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
CNR vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $622.0M |
| Net Profit | $-79.0M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | -9.3% | 62.4% |
| Net Margin | -7.6% | 34.4% |
| Revenue YoY | 81.8% | 4.8% |
| Net Profit YoY | -356.3% | 2.9% |
| EPS (diluted) | $-1.51 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $622.0M | ||
| Q3 25 | $1.0B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $573.6M | $593.6M | ||
| Q3 24 | $553.4M | $564.7M | ||
| Q2 24 | $490.7M | $537.3M | ||
| Q1 24 | $546.7M | $568.0M |
| Q4 25 | $-79.0M | $214.2M | ||
| Q3 25 | $31.6M | $288.2M | ||
| Q2 25 | $-36.6M | $30.2M | ||
| Q1 25 | $-69.3M | $238.3M | ||
| Q4 24 | $30.8M | $208.2M | ||
| Q3 24 | $95.6M | $544.0M | ||
| Q2 24 | $58.1M | $102.0M | ||
| Q1 24 | $101.9M | $4.8M |
| Q4 25 | -9.3% | 62.4% | ||
| Q3 25 | -1.2% | 70.1% | ||
| Q2 25 | -1.7% | 36.3% | ||
| Q1 25 | -5.3% | 94.0% | ||
| Q4 24 | 6.6% | 60.9% | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 14.6% | 50.2% | ||
| Q1 24 | 22.7% | -13.0% |
| Q4 25 | -7.6% | 34.4% | ||
| Q3 25 | 3.2% | 47.3% | ||
| Q2 25 | -3.3% | 5.2% | ||
| Q1 25 | -6.8% | 41.9% | ||
| Q4 24 | 5.4% | 35.1% | ||
| Q3 24 | 17.3% | 96.3% | ||
| Q2 24 | 11.8% | 19.0% | ||
| Q1 24 | 18.6% | 0.8% |
| Q4 25 | $-1.51 | $0.49 | ||
| Q3 25 | $0.61 | $0.67 | ||
| Q2 25 | $-0.70 | $0.07 | ||
| Q1 25 | $-1.38 | $0.55 | ||
| Q4 24 | $1.04 | $0.46 | ||
| Q3 24 | $3.22 | $1.21 | ||
| Q2 24 | $1.96 | $0.23 | ||
| Q1 24 | $3.39 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $432.2M | $618.7M |
| Total DebtLower is stronger | $354.2M | $9.0B |
| Stockholders' EquityBook value | $3.7B | $9.7B |
| Total Assets | $6.1B | $19.6B |
| Debt / EquityLower = less leverage | 0.10× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $432.2M | $618.7M | ||
| Q3 25 | $444.7M | $938.9M | ||
| Q2 25 | $413.2M | $631.9M | ||
| Q1 25 | $388.5M | $1.1B | ||
| Q4 24 | $460.2M | $929.0M | ||
| Q3 24 | $331.7M | $950.1M | ||
| Q2 24 | $216.1M | $1.8B | ||
| Q1 24 | $172.6M | $843.0M |
| Q4 25 | $354.2M | $9.0B | ||
| Q3 25 | $334.5M | $8.9B | ||
| Q2 25 | $334.0M | $8.0B | ||
| Q1 25 | $329.8M | $7.6B | ||
| Q4 24 | $94.8M | $7.6B | ||
| Q3 24 | $83.7M | $7.6B | ||
| Q2 24 | $184.9M | $7.6B | ||
| Q1 24 | $185.5M | $6.1B |
| Q4 25 | $3.7B | $9.7B | ||
| Q3 25 | $3.8B | $9.6B | ||
| Q2 25 | $3.8B | $9.5B | ||
| Q1 25 | $3.9B | $9.8B | ||
| Q4 24 | $1.6B | $10.3B | ||
| Q3 24 | $1.5B | $10.3B | ||
| Q2 24 | $1.4B | $9.8B | ||
| Q1 24 | $1.4B | $9.9B |
| Q4 25 | $6.1B | $19.6B | ||
| Q3 25 | $6.2B | $19.3B | ||
| Q2 25 | $6.2B | $18.3B | ||
| Q1 25 | $6.3B | $17.6B | ||
| Q4 24 | $2.9B | $18.2B | ||
| Q3 24 | $2.8B | $18.0B | ||
| Q2 24 | $2.7B | $17.7B | ||
| Q1 24 | $2.7B | $16.1B |
| Q4 25 | 0.10× | 0.92× | ||
| Q3 25 | 0.09× | 0.93× | ||
| Q2 25 | 0.09× | 0.84× | ||
| Q1 25 | 0.08× | 0.78× | ||
| Q4 24 | 0.06× | 0.74× | ||
| Q3 24 | 0.05× | 0.74× | ||
| Q2 24 | 0.13× | 0.78× | ||
| Q1 24 | 0.13× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.3M | $827.1M |
| Free Cash FlowOCF − Capex | $26.0M | — |
| FCF MarginFCF / Revenue | 2.5% | — |
| Capex IntensityCapex / Revenue | 7.8% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $21.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.3M | $827.1M | ||
| Q3 25 | $87.9M | $702.6M | ||
| Q2 25 | $220.2M | $364.0M | ||
| Q1 25 | $-109.6M | $596.1M | ||
| Q4 24 | $121.3M | $742.5M | ||
| Q3 24 | $161.3M | $703.6M | ||
| Q2 24 | $116.3M | $658.2M | ||
| Q1 24 | $77.5M | $664.6M |
| Q4 25 | $26.0M | — | ||
| Q3 25 | $38.6M | — | ||
| Q2 25 | $131.0M | — | ||
| Q1 25 | $-174.5M | — | ||
| Q4 24 | $80.5M | — | ||
| Q3 24 | $121.9M | — | ||
| Q2 24 | $60.9M | — | ||
| Q1 24 | $35.1M | — |
| Q4 25 | 2.5% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 11.9% | — | ||
| Q1 25 | -17.1% | — | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 6.4% | — |
| Q4 25 | 7.8% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 11.3% | — | ||
| Q1 24 | 7.7% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | 2.78× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 3.94× | 3.57× | ||
| Q3 24 | 1.69× | 1.29× | ||
| Q2 24 | 2.00× | 6.45× | ||
| Q1 24 | 0.76× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CNR
| Other | $397.4M | 38% |
| Power Generation | $376.5M | 36% |
| PRB | $183.0M | 18% |
| Metallurgical | $42.0M | 4% |
| Industrial | $34.1M | 3% |
| Terminal Revenue | $6.4M | 1% |
| Other Revenue | $3.0M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
